{
  "retracted": true,
  "timestamp": 1354579200000,
  "updates": [
    {
      "timestamp": 1585389636925,
      "identifier": {
        "doi": "10.1038/bjc.2012.497"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/sj.bjc.6605972"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Retraction Note: Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab"
}
